Research.Patient.info

T-cell Non-Hodgkin Lymphoma research hub

1 indexed studies · 0 currently recruiting

authorisedHuman Pharmacology (Phase I)- First administration to humans
A First-in-Human Study of KK2223 in Participants with T-cell Non-Hodgkin Lymphoma
This study is looking into a new medicine, KK2223, for people in the UK who have a type of blood cancer called T-cell non-Hodgkin lymphoma. It's the very first time this medicine is being tested in humans to see if it's safe and how it works.
Spain · Italy